Stahl Andrew 13D and 13G filings for Arch Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-08-09 11:16 am Purchase | 2023-07-12 | 13G | Arch Therapeutics, Inc. ARTH | Stahl Andrew | 300,000 9.890% | 300,000 (New Position) | Filing |